SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
闪闪kaka
Lv2
130 积分
2023-05-23 加入
最近求助
最近应助
互助留言
A rare case of infection and spontaneous rupture in ovarian mucinous cystadenoma
9个月前
已完结
Diagnostic value of inflammatory indicators for surgical site infection in patients with breast cancer
9个月前
已完结
Impact of the insertion site of central venous catheters on central venous catheter-related bloodstream infections in patients with cancer: results from a large prospective registry
9个月前
已完结
Occurrence rate and risk factors for long‐term central line‐associated bloodstream infections in patients with cancer: A systematic review
9个月前
已完结
First-line systemic treatment strategies for unresectable hepatocellular carcinoma: A cost-effectiveness analysis
11个月前
已完结
Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients
11个月前
已完结
Lenvatinib in the treatment of unresectable hepatocellular carcinoma: a systematic review of economic evaluations
11个月前
已完结
How the National Health Insurance Coverage policy changed the use of lenvatinib for adult patients with advanced hepatocellular carcinoma: a retrospective cohort analysis with real world big data
11个月前
已完结
Efficacy and safety of atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a systematic review and meta-analysis
11个月前
已完结
Efficacy of lenvatinib versus sorafenib in the primary treatment of advanced hepatocellular carcinoma: A meta‐analysis
11个月前
已完结
没有进行任何应助
标题错误。不是我所求助的文章。
1年前
速度真快,点赞,感谢
1年前
速度真快,感谢,点赞
1年前
速度真快,感谢
1年前
速度真快,感谢
1年前
速度真快,感谢,点赞
1年前
点赞,感谢,速度真快
1年前
感谢,点赞,速度真快
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论